Cargando…

Acute and Late Toxicity after Moderate Hypofractionation with Simultaneous Integrated Boost (SIB) Radiation Therapy for Prostate Cancer. A Single Institution, Prospective Study

To evaluate the acute and late toxicity using moderately hypofractionated, intensity-modulated radiotherapy (IMRT) with a simultaneous integrated boost (SIB) to prostate for patients with intermediate and high risk prostate cancer. From 2015 to 2017, 162 patients were treated with IMRT with SIB to t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jorgo, Kliton, Polgar, Csaba, Major, Tibor, Stelczer, Gabor, Herein, Andras, Pocza, Tamas, Gesztesi, Laszlo, Agoston, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242260/ https://www.ncbi.nlm.nih.gov/pubmed/30888646 http://dx.doi.org/10.1007/s12253-019-00623-2

Ejemplares similares

Acute Side Effects After Definitive Stereotactic Body Radiation Therapy (SBRT) for Patients with Clinically Localized Or Locally Advanced Prostate Cancer: a Single Institution Prospective Study
por: Jorgo, Kliton, et al.
Publicado: (2021)

Comparative dosimetrical analysis of intensity-modulated arc therapy, CyberKnife therapy and image-guided interstitial HDR and LDR brachytherapy of low risk prostate cancer
por: Fröhlich, Georgina, et al.
Publicado: (2021)

Relationship between biodosimetric parameters and treatment volumes in three types of prostate radiotherapy
por: Kocsis, Zsuzsa S., et al.
Publicado: (2021)

Biological dose summation of intensity-modulated arc therapy and image-guided high-dose-rate interstitial brachytherapy in intermediate- and high-risk prostate cancer
por: Fröhlich, Georgina, et al.
Publicado: (2020)

Multicatheter Interstitial Brachytherapy Versus Stereotactic Radiotherapy with CyberKnife for Accelerated Partial Breast Irradiation: A Comparative Treatment Planning Study with Respect to Dosimetry of Organs at Risk
por: Herein, András, et al.
Publicado: (2021)

Prostate Cancer Survivors Present Long-Term, Residual Systemic Immune Alterations
por: Balázs, Katalin, et al.
Publicado: (2022)

CyberKnife versus multicatheter interstitial brachytherapy for accelerated partial breast irradiation: a dosimetrical assessment with focus on organs at risk
por: Herein, András, et al.
Publicado: (2022)

External Beam Accelerated Partial Breast Irradiation: Dosimetric Assessment of Conformal and Three Different Intensity Modulated Techniques
por: Stelczer, Gábor, et al.
Publicado: (2019)

Simultaneous integrated boost (SIB) to dominant intra-prostatic lesions during extreme hypofractionation for prostate cancer: the impact of rectal spacers
por: Osman, Sarah O. S., et al.
Publicado: (2022)

Quantifying biological effects of radiation from high-energy linear accelerators on lymphocytes
por: Farkas, Gyöngyi, et al.
Publicado: (2019)

Comparison of breast simultaneous integrated boost (SIB) radiotherapy techniques
por: Aly, Moamen M.O.M., et al.
Publicado: (2015)

Chromosomal Aberrations in Blood Lymphocytes as Predictors of Respiratory Function After Stereotactic Lung Irradiation
por: Kocsis, Zsuzsa S., et al.
Publicado: (2022)

IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients
por: Studer, G, et al.
Publicado: (2006)

Dosimetric feasibility of moderately hypofractionated/dose escalated radiation therapy for localised prostate cancer with intensity-modulated proton beam therapy using simultaneous integrated boost (SIB-IMPT) and impact of hydrogel prostate-rectum spacer
por: Ahmad Khalil, Dalia, et al.
Publicado: (2022)

Comparing Outcomes of Oligometastases Treated with Hypofractionated Image-Guided Radiotherapy (HIGRT) with a Simultaneous Integrated Boost (SIB) Technique versus Metastasis Alone: A Multi-Institutional Analysis
por: Shenker, Rachel F., et al.
Publicado: (2022)

Accelerated partial breast irradiation with 3-dimensional conformal and image-guided intensity-modulated radiotherapy following breast conserving surgery – 7-Year results of a phase II trial
por: Mészáros, Norbert, et al.
Publicado: (2020)

Moderately Hypofractionated Radiotherapy with Simultaneous Integrated Boost in Prostate Cancer: A Comparative Study with Conventionally Fractionated Radiation
por: Cante, Domenico, et al.
Publicado: (2020)

The value of brachytherapy in the age of advanced external beam radiotherapy: a review of the literature in terms of dosimetry
por: Major, Tibor, et al.
Publicado: (2021)

Dosimetric comparison of inverse optimisation methods versus forward optimisation in HDR brachytherapy of breast, cervical and prostate cancer
por: Fröhlich, Georgina, et al.
Publicado: (2019)

Implementation of Stereotactic Accelerated Partial Breast Irradiation Using Cyber-Knife – Technical Considerations and Early Experiences of a Phase II Clinical Study
por: Mészáros, Norbert, et al.
Publicado: (2020)

Simultaneously integrated boost (SIB) spares OAR and reduces treatment time in locally advanced cervical cancer
por: Feng, Christine H., et al.
Publicado: (2016)

Biological dose summation of external beam radiotherapy for the whole breast and image-guided high-dose-rate interstitial brachytherapy boost in early-stage breast cancer
por: Fröhlich, Georgina, et al.
Publicado: (2020)

Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study
por: Yadav, Budhi Singh, et al.
Publicado: (2022)

Verification of An Optimizer Algorithm By the Beam Delivery Evaluation of Intensity-modulated Arc Therapy Plans
por: Pocza, Tamas, et al.
Publicado: (2021)

Simultaneous Integrated Boost (SIB) vs. Sequential Boost in Head and Neck Cancer (HNC) Radiotherapy: A Radiomics-Based Decision Proof of Concept
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Comparative analysis of toxicity in patients with anal cancer undergoing definitive simultaneous integrated boost (SIB) or sequential integrated boost (SeqB) radiotherapy
por: Rotondi, Margherita, et al.
Publicado: (2023)

Treatment planning for multicatheter interstitial brachytherapy of breast cancer – from Paris system to anatomy-based inverse planning
por: Major, Tibor, et al.
Publicado: (2017)

Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
por: Kornhuber, Christine, et al.
Publicado: (2023)

Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experience
por: Zhong, Liangzhi, et al.
Publicado: (2019)

Ten Year Results of Extensive Nodal Radiotherapy and Moderately Hypofractionated Simultaneous Integrated Boost in Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer
por: Di Muzio, Nadia Gisella, et al.
Publicado: (2021)

Simultaneous integrated boost (SIB) radiation therapy of right sided breast cancer with and without flattening filter - A treatment planning study
por: Maier, Johannes, et al.
Publicado: (2016)

Assessment of dose homogeneity in conformal interstitial breast brachytherapy with special respect to ICRU recommendations
por: Major, Tibor, et al.
Publicado: (2011)

Moderate hypofractionation for prostate cancer
por: Arcangeli, Stefano, et al.
Publicado: (2017)

Moderate hypofractionation for prostate cancer
por: Lee, W. Robert, et al.
Publicado: (2018)

A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer – the 3JECROG P-01 study protocol
por: Li, Chen, et al.
Publicado: (2019)

Five-year survival outcomes of intensity-modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) using forward IMRT or Tomotherapy for breast cancer
por: Lee, Hsin-Hua, et al.
Publicado: (2020)

Feasibility and Outcomes of Hypofractionated Simultaneous Integrated Boost-Intensity Modulated Radiotherapy for Malignant Gliomas: A Preliminary Report
por: Cha, Jihye, et al.
Publicado: (2014)

Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial
por: Krug, David, et al.
Publicado: (2020)

Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: A systematic literature review
por: Schmitt, Martin, et al.
Publicado: (2022)

Acute skin toxicity of ultra-hypofractionated whole breast radiotherapy with simultaneous integrated boost for early breast cancer
por: Montero, Angel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s33d08uctafh4lomvnh131li6l